A new systematic review of observational and interventional studies examines the use of antioxidants in patients with COVID-19. Published in the Food Science & Nutrition journal, the results demonstrate highly beneficial roles for this class of micronutrients in reducing inflammation, ventilation requirement, hospitalization, intensive care unit admission, mortality, and other aspects of coronavirus care. Confirming that intravenous supplementation with vitamin C significantly decreases mortality from COVID-19 in severe cases, and that studies show vitamin D, selenium, and zinc similarly play positive roles in fighting the disease, the researchers conclude that antioxidants can improve clinical outcomes.
Patients sufficient in vitamin D have a lower risk of all-cause and cardiovascular disease mortality, suggesting an important therapeutic strategy, according to a study involving data from 4,570 osteoarthritis patients.
A new study suggests that vaccine confidence has declined significantly since the start of the COVID-19 pandemic.
According to the pharma industry, governments, and the mainstream media, the mRNA vaccines used against COVID-19 are proven to be safe and effective. Over the past […]
Regular curcumin supplementation during exercise may relieve associated muscle soreness and fatigue in adolescent athletes, according to a recent study from researchers in Taiwan.
Higher levels of omega 3 fatty acids found in seafood are associated with a moderately lower risk of chronic kidney disease and a slower decline in kidney function, finds a study published by the British Medical Journal.
Cystic Fibrosis Patients Can Benefit From Vitamin Supplements
Cystic fibrosis patients who supplement their diet with vitamin C can also derive greater benefit from another antioxidant, vitamin E, resulting in a reduction in damaging inflammation, a study led by Oregon State University suggests.